Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MLANA anticorps

L’anticorps anti-MLANA Monoclonal Souris est utilisé pour la détection de MLANA dans des échantillons de Humain, Souris et Rat. Il a été validé pour WB, IF, FACS et IHC (p).
N° du produit ABIN3026559
642,40 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour MLANA anticorps (ABIN3026559)

Antigène

Voir toutes MLANA Anticorps
MLANA (Melan A (MLANA))

Reactivité

  • 250
  • 118
  • 92
  • 38
  • 15
  • 1
Humain, Souris, Rat

Hôte

  • 126
  • 124
  • 1
Souris

Clonalité

  • 176
  • 75
Monoclonal

Conjugué

  • 112
  • 17
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 7
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MLANA est non-conjugé

Application

  • 169
  • 109
  • 106
  • 105
  • 74
  • 44
  • 43
  • 26
  • 26
  • 23
  • 16
  • 12
  • 11
  • 9
  • 5
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité

Carrier-free

Clone

M2-9E3
  • Fonction

    Melan-A Antibody (azide and preservative free)

    Attributs du produit

    This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. There are seven other melanoma associated antigens recognized by autologous cytotoxic T cells: MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MART-1 antibody labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. The antibody does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.

    Purification

    Protein G affinity chromatography

    Immunogène

    Recombinant human Melan-A protein was used as the immunogen for this antibody.

    Isotype

    IgG2b, kappa
  • Indications d'application

    The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Melan-A antibody to be titered up or down for optimal performance.

    1. Staining of formalin-fixed tissues is enhanced by boiling tissue sections in pH 9 10 mM Tris with 1 mM EDTA for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Agent conservateur

    Azide free

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store the Melan-A antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Antigène

    MLANA (Melan A (MLANA))

    Autre désignation

    Melan-A

    Sujet

    This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. There are seven other melanoma associated antigens recognized by autologous cytotoxic T cells: MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MART-1 antibody labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. The antibody does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.
Vous êtes ici:
Chat with us!